All lobbying filings

MEHLMAN CONSULTING, INC.

MEHLMAN CONSULTING, INC. filed a Q1 report for ELEVANCE HEALTH, INC. on April 20, 2026, reporting $90,000 in lobbying income.

Lobbying for ELEVANCE HEALTH, INC. · Health Benefits Provider

All filings by MEHLMAN CONSULTING, INC. · Everything ELEVANCE HEALTH, INC. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$90,000

What the client paid this registrant for the period.

Client based in

Indiana

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Health Issues

Issues related to health insurance price transparency. Issues related to prescription drug costs and delivery.

Medicare/Medicaid

Medicare Advantage, Medicare Part D, Medicaid Managed Care. Issues related to prescription drug costs and delivery. PBM Reform issues. CY 2027 Medicare Advantage Rate Notice.

Pharmacy

Prescription Drug Pricing.

Taxation/Internal Revenue Code

Issues related to enhanced premium tax credits, and tax-preferred accounts to help lower the cost of insurance.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.